Septerna (SEPN) Amortizatization of Intangibles (2024 - 2026)
Septerna (SEPN) recorded quarterly Amortizatization of Intangibles of $755000.0 in Q1 2026, down 14.88% quarter-over-quarter from $887000.0 in Q4 2025, and down 21.76% on a YoY basis from $965000.0 in Q1 2025.
Septerna (SEPN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Septerna's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $755000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 21.76% year-over-year to $755000.0; the TTM figure through Mar 2026 stood at $3.2 million (up 40.6% YoY), while the FY2025 annual figure was $3.4 million, up 144.54% from the prior year.
- Amortizatization of Intangibles was $755000.0 for Q1 2026 at Septerna, down from $887000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $975000.0 in Q2 2025 to a low of $72000.0 in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $623666.7 across 3 years, with a median of $755000.0 in 2026.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 1240.28% in 2025, then retreated 21.76% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $809000.0 in 2024, then grew by 9.64% to $887000.0 in 2025, then decreased by 14.88% to $755000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $755000.0 (Q1 2026), $887000.0 (Q4 2025), and $621000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,000.00 |
| Mar 31, 2026 | 755,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |